Anti-Infective Agents Market size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022

“Stratistics MRC, one stop shop for all your market research needs.”
According to Stratistics MRC, the Global Anti Infective Agents Market is accounted for $83.8 billion in 2015 and expected to grow at a CAGR of 3.2% to reach $104.5 billion by 2022. Rising incidences of infectious diseases such as HIV, H1N1, and Ebola virus, awareness amongst the healthcare professionals and the patients and commercialization of pipeline products are boosting the market growth.

Trends like treatment rates for communicable diseases in developing countries and treatment of Community Acquired Bacterial Pneumonia (CABP) are expected to impart the market growth. Growing resistance of infection to the drug therapies, high price of drugs, competition between generic manufacturers and perilous reimbursement policies will impede market growth.

Order a copy at

The antibacterial segment accounted for the largest share of revenue. The anti-viral agents segment is expected to grow during the forecast period. North America commanded the anti-infective agents market and is followed by Europe. Asia Pacific is the fastest growing market due to improvements in healthcare infrastructure, demand for drugs and ongoing government initiatiatives for various control programs and strategic partnership projects.

Some of the key players in global Anti-Infective Agents market are AstraZeneca Plc, Boehringer Ingelheim, Bristol-Myers Squibb Co, Abbott Laboratories, Bayer Healthcare AG, Cipla Ltd, Gilead Sciences,Claris Life Sciences Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Merck & Co., Inc, Novartis AG, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Panacea Biotech Ltd, Pfizer Ltd, Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd., Johnson & Johnson Inc., Sanofi Aventis S.A., Beijing Double-Crane Pharmaceutical Co., Ltd, Anhui Jingfang Medical Industry Co.,Ltd and Hoffman-La Roche, Inc.

Request for a sample at

Scope of the Report:

Products Covered:

• Antibacterial agents
o Cephalosporins
o Carbapenems
o Fluoroquinolones
o Macrolides
o Penicillins
o Clindamycin
o B-Lactam Antibiotics
o Oxazolidinones
o Aminoglycosides
o Quinolones
o Sulfonamides
o Tetracyclines
o Vancomycin
• Antifungal agents
o Azoles 
o Echinocandins
o Polyenes
o Allylamines
o Macrolides derivatives
o Cresemba
• Antiviral agents
o DNA Polymerase Inhibitors
o Nucleoside Analogs
o Non-structural protein 5A (NS5A) inhibitors  
o Non-nucleoside reverse transcriptase inhibitors (NNRTIs)  
o Protease Inhibitors  
o Transcriptase Inhibitors  
o Neuraminidase inhibitors  
o Integrase strand transfer inhibitor  
o Chemokine receptor antagonist
• Antituberculosis agents
o Aminosalicylates 
o Diarylquinolines 
o Hydrazide derivatives 
o Nicotinic acid derivatives 
o Rifamycin derivatives 
o Streptomyces derivatives
• Vaccines
o Live/attenuated Vaccines  
o Inactivated Vaccines  
o DNA & Recombinant vector Vaccines  
o Toxoid vaccines
• Antitreponemal agents

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Follow us on LinkedIn:

Follow us on Twitter:

About Stratistics MRC

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

For more information, please visit Stratistics Market Research Consulting Pvt Ltd

Media Contact
Company Name: Stratistics Market Research Consulting
Contact Person: James Lamb
Phone: +1-301-202-5929
City: Gaithersburg
State: Maryland
Country: United States